Mar 17, 2025 09:25AM

Jun 11, 2024 09:25AM

Jun 4, 2024 09:03AM

Sep 29, 2023 07:31AM

Mar 24, 2020 08:00AM

Mar 18, 2020 04:01PM

Mar 17, 2020 08:00AM Capricor Therapeutics Announces Strategic Plan for Exosome Platform Technology Products Expansion

Mar 11, 2020 04:30PM

Dec 19, 2019 01:14PM

Dec 17, 2019 01:54PM

Dec 17, 2019 01:52PM

Dec 13, 2019 05:04PM

Dec 13, 2019 09:22AM

Dec 5, 2019 08:02AM Form S-1 CAPRICOR THERAPEUTICS,

Aug 13, 2015 04:05PM

Aug 13, 2015 04:05PM

Aug 4, 2015 08:00AM

Jun 17, 2015 08:00AM

Jun 15, 2015 08:00AM

Jun 15, 2015 08:00AM

Jun 8, 2015 08:42AM Capricor Announces Receipt of FDA Clearance for the Phase I/II Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy Related Cardiomyopathy

Jun 8, 2015 08:42AM

May 12, 2015 04:01PM

May 12, 2015 04:01PM

Apr 22, 2015 08:00AM

Apr 8, 2015 08:00AM

Apr 8, 2015 08:00AM

Mar 31, 2015 08:00AM Capricor Therapeutics Completes Enrollment of Phase II Clinical Trial for Cenderitide to Treat Heart Failure

Mar 18, 2015 04:05PM

Mar 18, 2015 04:05PM

Mar 6, 2015 05:23PM

Mar 5, 2015 09:00AM

Mar 5, 2015 09:00AM

Mar 5, 2015 08:00AM

Mar 5, 2015 08:00AM Capricor Therapeutics Announces Uplisting to NASDAQ Capital Market

Jan 21, 2015 08:00AM

Jan 12, 2015 12:32PM

Dec 2, 2014 07:45AM

Nov 18, 2014 07:45AM

Oct 31, 2014 08:00AM

Oct 9, 2014 08:22AM

Aug 13, 2014 10:18AM Capricor Therapeutics Reports Second Quarter 2014 Financial & Business Highlights

Aug 4, 2014 08:27AM

Jul 16, 2014 07:59AM

Jun 23, 2014 09:02AM

Jun 19, 2014 01:28PM

May 28, 2014 02:36PM

66,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All